{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:56Z","timestamp":1786995656596,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.phrs.2023.106750","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T15:31:00Z","timestamp":1680276660000},"page":"106750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"192","author":[{"given":"Enrico","family":"Gugliandolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Macr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Siracusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Cordaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"D\u2019amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio Filippo","family":"Peritore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Impellizzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Crupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2023.106750_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S2213-2600(17)30498-8","article-title":"Redefining pulmonary hypertension","volume":"6","author":"Maron","year":"2018","journal-title":"Lancet Respir. Med"},{"issue":"1","key":"10.1016\/j.phrs.2023.106750_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cveq.2019.01.001","article-title":"Overview of equine cardiac disease","volume":"35","author":"Bonagura","year":"2019","journal-title":"Vet. Clin. North Am. Equine Pr."},{"issue":"2","key":"10.1016\/j.phrs.2023.106750_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jvim.15725","article-title":"ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs","volume":"34","author":"Reinero","year":"2020","journal-title":"J. Vet. Intern Med"},{"issue":"1","key":"10.1016\/j.phrs.2023.106750_bib4","first-page":"30","article-title":"Prognostic factors in pulmonary hypertension","volume":"7","author":"Corciova","year":"2012","journal-title":"Maedica (Bucur. )"},{"key":"10.1016\/j.phrs.2023.106750_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12020","article-title":"EXPRESS: Prevalence, Incidence, and Survival of Pulmonary Arterial Hypertension: A Systematic Review for the Global Burden of Disease 2020 Study","author":"Emmons-Bell","year":"2021","journal-title":"Pulm. Circ."},{"issue":"10","key":"10.1016\/j.phrs.2023.106750_bib6","first-page":"2260","article-title":"Short-term effects of sildenafil in the treatment of dogs with pulmonary hypertension secondary to degenerative mitral valve disease, Veterinary","volume":"13","author":"Saetang","year":"2020","journal-title":"World"},{"key":"10.1016\/j.phrs.2023.106750_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105287","article-title":"Resveratrol: mechanistic and therapeutic perspectives in pulmonary arterial hypertension","volume":"163","author":"Mirhadi","year":"2021","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.phrs.2023.106750_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmed.2016.11.005","article-title":"Targeting vascular remodeling to treat pulmonary arterial hypertension","volume":"23","author":"Thompson","year":"2017","journal-title":"Trends Mol. Med."},{"issue":"8","key":"10.1016\/j.phrs.2023.106750_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"issue":"Suppl 2","key":"10.1016\/j.phrs.2023.106750_bib10","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1916","article-title":"Interleukin-6: discovery of a pleiotropic cytokine","volume":"8","author":"Kishimoto","year":"2006","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"10.1016\/j.phrs.2023.106750_bib11","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106750_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5483\/BMBRep.2014.47.1.285","article-title":"Role of vascular smooth muscle cell in the inflammation of atherosclerosis","volume":"47","author":"Lim","year":"2014","journal-title":"BMB Rep."},{"issue":"4","key":"10.1016\/j.phrs.2023.106750_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00314-2020","article-title":"IL-6 in pulmonary hypertension: why novel is not always best","volume":"55","author":"Toshner","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.phrs.2023.106750_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCRESAHA.108.182014","article-title":"Interleukin-6 overexpression induces pulmonary hypertension","volume":"104","author":"Steiner","year":"2009","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2023.106750_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-10-6","article-title":"Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice","volume":"10","author":"Savale","year":"2009","journal-title":"Respir. Res"},{"issue":"6","key":"10.1016\/j.phrs.2023.106750_bib16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/1744666X.2019.1596800","article-title":"Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?","volume":"15","author":"Theoharides","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.phrs.2023.106750_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106238","article-title":"Immunity and inflammation in pulmonary arterial hypertension: from pathophysiology mechanisms to treatment perspective","volume":"180","author":"Wang","year":"2022","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.phrs.2023.106750_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/2045893217735820","article-title":"Clinical trial protocol for TRANSFORM-UK: a therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertension","volume":"8","author":"Hernandez-Sanchez","year":"2018","journal-title":"Pulm. Circ."},{"issue":"7","key":"10.1016\/j.phrs.2023.106750_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/jop.2017.0017","article-title":"Tolerability of topical tocilizumab eyedrops in dogs: a pilot study","volume":"33","author":"Bunya","year":"2017","journal-title":"J. Ocul. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2023.106750_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10937409809524557","article-title":"Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system","volume":"1","author":"Schultze","year":"1998","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.phrs.2023.106750_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pupt.2015.09.007","article-title":"Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: A network approach","volume":"35","author":"Nogueira-Ferreira","year":"2015","journal-title":"Pulm. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2023.106750_bib22","doi-asserted-by":"crossref","first-page":"L363","DOI":"10.1152\/ajplung.00212.2011","article-title":"The monocrotaline model of pulmonary hypertension in perspective","volume":"302","author":"Gomez-Arroyo","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106750_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10741-018-9762-4","article-title":"Current animal models for the study of congestion in heart failure: an overview","volume":"24","author":"Cops","year":"2019","journal-title":"Heart Fail Rev."},{"issue":"2","key":"10.1016\/j.phrs.2023.106750_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3892\/ijmm.2020.4813","article-title":"Astragaloside IV blocks monocrotaline\u2011induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling","volume":"47","author":"Jin","year":"2021","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.phrs.2023.106750_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111081","article-title":"Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats","volume":"133","author":"Tang","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2023.106750_bib26","article-title":"Comprehensive analysis and validation of novel immune and vascular remodeling related genes signature associated with drug interactions in pulmonary arterial hypertension","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"issue":"18","key":"10.1016\/j.phrs.2023.106750_bib27","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1113\/JP280389","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"598","author":"Percie du Sert","year":"2020","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106750_bib28","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41467-019-11500-6","article-title":"CD146-HIF-1alpha hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension","volume":"10","author":"Luo","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2023.106750_bib29","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-019-13139-9","article-title":"A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension","volume":"10","author":"Arnold","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.phrs.2023.106750_bib30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.pain.2013.03.026","article-title":"Inhibition of IL-6 signaling: A novel therapeutic approach to treating spinal cord injury pain","volume":"154","author":"Guptarak","year":"2013","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.phrs.2023.106750_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.expneurol.2010.04.020","article-title":"Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation","volume":"224","author":"Mukaino","year":"2010","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106750_bib32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yjmcc.2006.12.004","article-title":"Anti-rat soluble IL-6 receptor antibody down-regulates cardiac IL-6 and improves cardiac function following trauma-hemorrhage","volume":"42","author":"Yang","year":"2007","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2023.106750_bib33","article-title":"Right ventricular systolic pressure measurements in combination with harvest of lung and immune tissue samples in mice","volume":"71","author":"Chen","year":"2013","journal-title":"J. Vis. Exp."},{"issue":"11","key":"10.1016\/j.phrs.2023.106750_bib34","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1084\/jem.20112716","article-title":"Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension","volume":"209","author":"Hameed","year":"2012","journal-title":"J. Exp. Med"},{"issue":"3","key":"10.1016\/j.phrs.2023.106750_bib35","first-page":"71","article-title":"An improvement of the 2^(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis","volume":"3","author":"Rao","year":"2013","journal-title":"Biostat. Bioinforma. Biomath."},{"issue":"9","key":"10.1016\/j.phrs.2023.106750_bib36","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (Actemra)","volume":"13","author":"Sheppard","year":"2017","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.phrs.2023.106750_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/720305","article-title":"Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension","volume":"2010","author":"Furuya","year":"2010","journal-title":"Int J. Rheuma"},{"issue":"2","key":"10.1016\/j.phrs.2023.106750_bib38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/14397595.2018.1546357","article-title":"IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review","volume":"29","author":"Ogata","year":"2019","journal-title":"Mod. Rheuma"},{"issue":"3","key":"10.1016\/j.phrs.2023.106750_bib39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/1078155220948934","article-title":"Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease","volume":"27","author":"Melgarejo-Ortuno","year":"2021","journal-title":"J. Oncol. Pharm. Pr."},{"key":"10.1016\/j.phrs.2023.106750_bib40","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.933973","article-title":"Editorial: tocilizumab, a humanized therapeutic IL-6 receptor (IL-6R) monoclonal antibody, and future combination therapies for severe COVID-19","volume":"27","author":"Parums","year":"2021","journal-title":"Med Sci. Monit."},{"issue":"9","key":"10.1016\/j.phrs.2023.106750_bib41","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","article-title":"Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension","volume":"122","author":"Soon","year":"2010","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.phrs.2023.106750_bib42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s13071-017-2426-8","article-title":"Acute phase proteins and markers of oxidative stress to assess the severity of the pulmonary hypertension in heartworm-infected dogs","volume":"10","author":"Carreton","year":"2017","journal-title":"Parasit. Vectors"},{"issue":"2","key":"10.1016\/j.phrs.2023.106750_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/vcp.12255","article-title":"Interleukin-6 as a prognostic marker in dogs in an intensive care unit","volume":"44","author":"Schuttler","year":"2015","journal-title":"Vet. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.phrs.2023.106750_bib44","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2746\/042516400777584604","article-title":"Clenbuterol administration does not attenuate the exercise-induced pulmonary arterial, capillary or venous hypertension in strenuously exercising Thoroughbred horses","volume":"32","author":"Manohar","year":"2000","journal-title":"Equine Vet. J."},{"issue":"5","key":"10.1016\/j.phrs.2023.106750_bib45","first-page":"317","article-title":"Intravenous pentoxifylline does not affect the exercise-induced pulmonary arterial, capillary or venous hypertension in Thoroughbred horses","volume":"23","author":"Manohar","year":"2000","journal-title":"J. Vet. Pharm. Ther."},{"key":"10.1016\/j.phrs.2023.106750_bib46","article-title":"Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: evidence for IL-6 as a potential target against AHR in equine asthma","volume":"73\u201374","author":"Calzetta","year":"2022","journal-title":"Pulm. Pharm. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2023.106750_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239561","article-title":"Severe asthma is associated with a remodeling of the pulmonary arteries in horses","volume":"15","author":"Ceriotti","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2023.106750_bib48","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cvr\/cvy013","article-title":"IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis","volume":"114","author":"Chou","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.phrs.2023.106750_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13425","article-title":"Let-7 mediated airway remodelling in chronic obstructive pulmonary disease via the regulation of IL-6","volume":"51","author":"Di","year":"2021","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.phrs.2023.106750_bib50","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.freeradbiomed.2019.01.044","article-title":"Hypochlorous acid-modified extracellular matrix contributes to the behavioral switching of human coronary artery smooth muscle cells","volume":"134","author":"Cai","year":"2019","journal-title":"Free Radic. Biol. Med"},{"issue":"6","key":"10.1016\/j.phrs.2023.106750_bib51","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2006.02.039","article-title":"The role of the mast cell in the pathophysiology of asthma","volume":"117","author":"Bradding","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2023.106750_bib52","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/all.13666","article-title":"Mast cell chymase impairs bronchial epithelium integrity by degrading cell junction molecules of epithelial cells","volume":"74","author":"Zhou","year":"2019","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.phrs.2023.106750_bib53","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.CIR.50.5.905","article-title":"Echocardiographic patterns of pulmonic valve motion with pulmonary hypertension","volume":"50","author":"Weyman","year":"1974","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phrs.2023.106750_bib54","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00740-2017","article-title":"Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model","volume":"50","author":"Hoeper","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2023.106750_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejps.2013.08.004","article-title":"Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension","author":"Lee","year":"2013","journal-title":"Eur. J. Pharm. Sci. 50("},{"issue":"6","key":"10.1016\/j.phrs.2023.106750_bib56","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ehjci\/jew024","article-title":"Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy","volume":"17","author":"Ong","year":"2016","journal-title":"Eur. Heart J. Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.phrs.2023.106750_bib57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12917-020-02531-z","article-title":"Spontaneous tricuspid valve chordal rupture in a dog with severe, irreversible pulmonary hypertension caused by Angiostrongylus vasorum infection","volume":"16","author":"Szatmari","year":"2020","journal-title":"BMC Vet. Res"},{"issue":"15","key":"10.1016\/j.phrs.2023.106750_bib58","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14532","article-title":"Adaptive and innate immune mechanisms in cardiac fibrosis complicating pulmonary arterial hypertension","volume":"8","author":"Siamwala","year":"2020","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.phrs.2023.106750_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105912","article-title":"Management of inflammation in cardiovascular diseases","volume":"173","author":"Goswami","year":"2021","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2023.106750_bib60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2019.02.022","article-title":"Myeloperoxidase - a bridge linking inflammation and oxidative stress with cardiovascular disease","volume":"493","author":"Ndrepepa","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.phrs.2023.106750_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108674","article-title":"The role of interleukin-6\/interleukin-6 receptor signaling in the mechanical stress-induced extracellular matrix remodeling of bladder smooth muscle","volume":"702","author":"He","year":"2021","journal-title":"Arch. Biochem Biophys."},{"issue":"16","key":"10.1016\/j.phrs.2023.106750_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10163757","article-title":"Role of the immune system elements in pulmonary arterial hypertension","volume":"10","author":"Tomaszewski","year":"2021","journal-title":"J. Clin. Med"},{"issue":"5","key":"10.1016\/j.phrs.2023.106750_bib63","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.21037\/jtd.2018.05.59","article-title":"New dynamic viewing of mast cells in pulmonary arterial hypertension (PAH): contributors or outsiders to cardiovascular remodeling","volume":"10","author":"Xu","year":"2018","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2023.106750_bib64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4149\/gpb_2021007","article-title":"The role of pulmonary mast cells activation and degranulation in the process of increased pulmonary artery pressure","volume":"40","author":"Liu","year":"2021","journal-title":"Gen. Physiol. Biophys."},{"issue":"6","key":"10.1016\/j.phrs.2023.106750_bib65","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.jaci.2015.09.059","article-title":"IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3","volume":"137","author":"Desai","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106750_bib66","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.1102389","article-title":"Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-beta","volume":"188","author":"Ganeshan","year":"2012","journal-title":"J. Immunol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:42:36Z","timestamp":1760913756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823001068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":66,"alternative-id":["S1043661823001068"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106750","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106750"}}